Notice Concerning Appointment of Executive Officers and Organizational Changes
Filed with TSE · · 1 page · English
Summary by 6ix AI
Fuso Pharmaceutical Industries, Ltd. has announced changes in executive officers and organizational structure following a Board of Directors meeting. The changes will take effect at the beginning of the next year, including the retirement of an executive officer and new appointments. Additionally, new sections will be established within the Pharmacovigilance Department to enhance operations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Fuso Pharmaceutical Industries,Ltd. on 6ix
In the deck
Story so far
Earlier from Fuso Pharmaceutical Industries,Ltd
- Notice Concerning Revisions to Financial Result Forecasts for the Six Months Ended September 30, 2026
- Notice Concerning Conclusion of Design-Build Contract for Okayama Second Factory
- [Updated]Non-consolidated Financial Results for the Three Months Ended June 30, 2026[Under Japanese GAAP]
- TABLE-Fuso Pharmaceutical - 9-MTH parent results
- TABLE-Fuso Pharmaceutical - 6-MTH parent results
Follow Fuso Pharmaceutical Industries,Ltd into a list and get an email when it puts out news.
Follow Fuso Pharmaceutical Industries,Ltd